NASDAQ:CLBTW

Cellebrite DI (CLBTW) Stock Price, News & Analysis

$1.95
-0.27 (-12.16%)
(As of 10:11 AM ET)
Today's Range
$1.95
$2.14
50-Day Range
$1.79
$2.88
52-Week Range
$0.71
$2.94
Volume
11,710 shs
Average Volume
62,950 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

CLBTW Stock Price History

CLBTW Stock News Headlines

Cellebrite: Big Fish In A Small Pond
The biggest energy story ever?
Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…
Cellebrite DI Ltd CLBT
UPDATE - Cellebrite Announces 2024 Investor Day
Trump’s last act as President
You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.
See More Headlines
Receive CLBTW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Software - Infrastructure
Sub-Industry
N/A
Current Symbol
NASDAQ:CLBTW
Fax
N/A
Employees
1,008
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$325.11 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Yossi Carmil (Age 56)
    Founder, CEO & Director
    Comp: $1.14M
  • Ms. Dana Gerner (Age 57)
    Chief Financial Officer
    Comp: $649k
  • Mr. Ronnen Armon (Age 61)
    Chief Products & Technologies Officer
    Comp: $516k
  • Mr. Leeor Ben-Peretz (Age 48)
    Chief Strategy Officer
    Comp: $470k
  • Mr. Thomas E. Hogan (Age 65)
    Executive Chairman
  • Mr. Arnon Zilberman
    Executive Vice President of Information Systems & Operations
  • Andrew Kramer
    Vice President of Investor Relations
  • Ms. Ayala Berler Shapira (Age 53)
    General Counsel & Chief Compliance Officer
  • Mr. David Nicholas Gee (Age 57)
    Chief Marketing Officer
  • Ms. Zohar Tadmor-Eilat (Age 53)
    Chief People Officer

CLBTW Stock Analysis - Frequently Asked Questions

How have CLBTW shares performed in 2024?

Cellebrite DI's stock was trading at $1.57 at the start of the year. Since then, CLBTW shares have increased by 41.4% and is now trading at $2.22.
View the best growth stocks for 2024 here
.

Are investors shorting Cellebrite DI?

Cellebrite DI saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 6,500 shares, an increase of 16.1% from the March 31st total of 5,600 shares. Based on an average trading volume of 64,200 shares, the days-to-cover ratio is presently 0.1 days.
View Cellebrite DI's Short Interest
.

How do I buy shares of Cellebrite DI?

Shares of CLBTW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLBTW) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners